New Diagnostic and Therapeutic Developments in Eye and Systemic Diseases

Dear Colleagues,

Ophthalmology has been at the forefront of medical innovation due to its unique demand for device-assisted diagnostics and microsurgery. Recent technological developments have radically impacted the daily practices of ophthalmologists thanks to the advent of novel diagnostic and therapeutic tools that facilitate the early diagnosis of eye diseases and systemic diseases (i.e., oculomics), allowing for the better management of not only ocular disorders but also systemic disorders affecting the entire body. The use of modern devices not only permits the earlier detection of eye diseases and systemic diseases but also allows ophthalmologists to offer more individualized treatment to their patients. For this Special Issue, we request research including new findings in the fields of diagnostic and therapeutic developments in eye diseases and systemic diseases. Our goal is to discuss, amongst others, diagnostic imaging, molecular pathology diagnosis (biomarkers), artificial intelligence diagnosis, and innovative treatment options in the field of ophthalmology.

Primarily, we welcome submissions of high-quality original research articles showcasing new developments and innovative findings on these topics. Secondarily, we will consider high-interest review articles and case series of exceptional quality.

Dr. Zhihong Jewel Hu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.